Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 25, 2019

SELL
$4.03 - $5.44 $5,968 - $8,056
-1,481 Closed
0 $0
Q2 2018

Jul 25, 2018

BUY
$13.66 - $21.0 $20,230 - $31,101
1,481 New
1,481 $20,000

Others Institutions Holding VRNA

About Verona Pharma plc


  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $2.56B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Old Second National Bank Of Aurora Portfolio

Follow Old Second National Bank Of Aurora and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Second National Bank Of Aurora, based on Form 13F filings with the SEC.

News

Stay updated on Old Second National Bank Of Aurora with notifications on news.